dabigatran has been researched along with Reperfusion Injury in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, T; Gyoten, K; Hayasaki, A; Hibi, T; Iizawa, Y; Kishiwada, M; Kuriyama, N; Maeda, K; Mizuno, S; Murata, Y; Noguchi, D; Sakurai, H; Shinkai, T; Tanemura, A | 1 |
Bayramoğlu, Z; Caynak, B; Karahan, O; Oral, MK; Sagbas, E; Unal, M; Yazici, S | 1 |
2 other study(ies) available for dabigatran and Reperfusion Injury
Article | Year |
---|---|
The Impact of Dabigatran Treatment on Sinusoidal Protection Against Hepatic Ischemia/Reperfusion Injury in Mice.
Topics: Animals; Dabigatran; Endothelial Cells; Hepatocytes; Humans; Ischemia; Liver; Liver Transplantation; Mice; Reperfusion Injury | 2021 |
Comparison of Renoprotective Effect of Dabigatran With Low-Molecular-Weight Heparin.
Topics: Animals; Biomarkers; Dabigatran; Dipeptidases; Heparin, Low-Molecular-Weight; Kidney; Kidney Diseases; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2016 |